journal article·2024-06Open access

Bioengineered Ionic Liquid for Catheter‐Directed Tissue Ablation, Drug Delivery, and Embolization (Adv. Mater. 23/2024)

Hyeongseop Keum, Hassan Albadawi, Zefu Zhang, Erin Graf, Pedro Reck Dos Santos, Seyda Gunduz, Rahmi Oklu

Advanced Materials· Volume 36· Issue 23

Abstract

Immunotherapy The image demonstrates the ionic liquid embolic exiting the tip of a catheter and filling the arteries of the tumor. The purple color depicts the ablation of the vessel wall and the adjacent tumor tissue as the ionic liquid diffuses across the vessel wall. As the ionic liquid diffuses trans-arterially, it carries its payload, which in this case is Nivolumab, an immunotherapy drug. Along the margins of the tumor ablation, Nivolumab is seen interacting with cells enabling immunotherapy to occur. More details can be found in article number 2309412 by Rahmi Oklu and co-workers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Intracranial Aneurysms: Treatment and Complications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Laboratory for Patient‐Inspired Engineering Mayo Clinic 13400 East Shea Blvd. Scottsdale AZ 85259 USA

Division of Vascular and Interventional Radiology Mayo Clinic 5777 E Mayo Blvd Phoenix AZ 85054 USA

Department of Laboratory Medicine and Pathology Mayo Clinic 5777 E Mayo Blvd Phoenix AZ 85054 USA

Department of Cardiothoracic Surgery Mayo Clinic 5777 E Mayo Blvd Phoenix AZ 85054 USA

Department of Medical Oncology Istinye University Bahcesehir Liv Hospital Istanbul 34517 Turkey

References

Reference metadata was not supplied for this record.